Cell and gene therapy shipments involve a complex sequence of events with precise planning and coordination of the stakeholders involved.

The medicines are unique and have vulnerable characteristics. The transport process involves the expedited movement of material from the patient to the manufacturing facility and then the return to the patient.

Download to find out more.